Contact allergy to isothiazolinones epidemic: Current situation-Reference-Cited by-同舟云学术

Contact allergy to isothiazolinones epidemic: Current situation

Published:2019-10-21 Issue:2 Volume:82 Page:83-86
ISSN:0105-1873
Container-title:Contact Dermatitis
language:en
Short-container-title:Contact Dermatitis

Author:

Magdaleno‐Tapial Jorge¹^ORCID,Valenzuela‐Oñate Cristian¹,Ortiz‐Salvador José M.¹^ORCID,García‐Legaz‐Martínez Marta¹,Martínez‐Domenech Álvaro¹,Alonso‐Carpio Miriam¹,Sierra Talamantes Concepción¹,Zaragoza‐Ninet María G.¹,Zaragoza‐Ninet Violeta¹

Affiliation:

1. Department of DermatologyHospital General Universitario de Valencia Valencia Spain

Publisher

Wiley

Subject

Dermatology,Immunology and Allergy

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/cod.13396

Reference9 articles.

1. Descriptive study of sensitization to methylchloroisothiazolinone and methylisothiazolinone in a skin allergy unit;Unamuno B;Actas Dermosifiliogr,2014

2. Allergy to Methyldibromoglutaronitrile/Phenoxyethanol (Euxyl K 400): Regulatory Issues, Epidemiology, Clinical Characteristics, and Management

3. The epidemic of methylisothiazolinone: a European prospective study

4. Methylisothiazolinone: the epidemic is declining - but not gone

5. Methylchloroisothiazolinone and methylisothiazolinone contact allergy: A retrospective cohort study from a tertiary dermatology clinic in Turkey

Cited by 21 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. L’eczéma de contact de l’enfant;Annales de Dermatologie et de Vénéréologie - FMC;2024-09

2. Allergic or Not: Final Interpretation of Doubtful Patch Test Reactions From the North American Contact Dermatitis Group, 2019–2020;Dermatitis®;2024-04-01

3. Sensitization to isothiazolinones in the Spanish Contact Dermatitis Registry (REIDAC): 2019–2021 epidemiological situation;Contact Dermatitis;2022-12

4. Allergic Contact Dermatitis Mimicking Anti–Interleukin 17 Eczematous Eruption;Dermatitis;2022-06-08

5. Genetic validation of Aspergillus fumigatus phosphoglucomutase as a viable therapeutic target in invasive aspergillosis;Journal of Biological Chemistry;2022-06